PowderMed seeks to start bird-flu vaccine trial
The Wall Street Journal Europe
11 Jul 2006
POWDERMED Ltd., a closely held U.K.-based vaccine company, said it applied to U.K. regulators for permission to conduct a clinical trial to test a needlefree vaccine targeting the deadly H5N1 strain of bird flu. The trial will study for the first... read more...
posted by Bank Report at
10:16 AM
0 Comments:
Post a Comment
<< Home